• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

NICE changes its mind on Lilly's Mounjaro for diabetes

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 08, 2023 at 10:22: AM
via Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiveness overseer NICE.

article source
 

<



Similar threads

cafead
Novartis changes NICE&#039;s mind on Kymriah, giving CAR-T rival Gilead some company
Replies
0
Views
156
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
After tense standoff, AstraZeneca and Daiichi&#039;s Enhertu turned away by NICE on pricing grounds
Replies
0
Views
37
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Lilly wins NICE endorsement for tirzepatide in obesity—with a catch
Replies
0
Views
67
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Surprise Enhertu rejection follows NICE process change
Replies
0
Views
50
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca, Merck&#039;s Lynparza picks up new NICE recommendation
Replies
0
Views
208
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote